BridgeBio Pharma SG&A Expense (TTM) Insights

BridgeBio Pharma Inc (BBIO)

24.91 -0.29 (-1.15%) USD | NASDAQ | Jul 02, 16:00

24.93 +0.02 (+0.08%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	185.29M
December 31, 2023	150.59M
September 30, 2023	134.87M
June 30, 2023	130.28M
March 31, 2023	130.58M
December 31, 2022	143.19M
September 30, 2022	166.08M
June 30, 2022	180.97M
March 31, 2022	190.52M
December 31, 2021	192.21M
September 30, 2021	174.90M

Date	Value
June 30, 2021	164.83M
March 31, 2021	156.83M
December 31, 2020	145.68M
September 30, 2020	143.22M
June 30, 2020	130.70M
March 31, 2020	109.72M
December 31, 2019	94.35M
September 30, 2019	73.76M
June 30, 2019	60.58M
March 31, 2019	54.48M
December 31, 2018	43.59M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

73.76M

Minimum

Sep 2019

192.21M

Maximum

Dec 2021

147.29M

Average

145.68M

Median

Dec 2020

SG&A Expense (TTM) Benchmarks